Project Grant HT94252410270
Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $321K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Great Britain, United Kingdom
Similar Awards
- Federal Grant Award Summary The University of Alabama at Birmingham received a $148,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded October 1, 2025, with a completion date of September 30, 2026. The award supports research investigating the polyol pathway's role in promoting renal cancer tumorigenesis through glucose-mediated lipogenesis mechanisms. This basic biomedical research project advances DHA's...
- The University of Alabama at Birmingham will receive $670,729 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on DNA damage as a predictive biomarker for immunotherapy response in ovarian cancer. The three-year project grant awarded in July 2021 will support research to investigate medical solutions for the battlefield by exploring DNA damage as a potential predictor of whether patients...
- Federal Project Grant Summary The University of Alabama at Birmingham received a $1,317,584 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2028. This research initiative focuses on developing macrophage-centric prognostic biomarkers to improve outcomes for checkpoint blockade immunotherapy in melanoma treatment. The three-year project will advance biomedical research...
- Federal Grant Award Summary The University of Alabama received a $525,799 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award supports research titled "Targeting GPNMB to Improve Efficacy of CDK4/6 Inhibitors in ER+ Breast Cancer," to be conducted at the university's Tuscaloosa, Alabama campus through the Office for Sponsored Programs. This research...
- Federal Project Grant Award Summary The University of Alabama at Birmingham received a $227,167 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2025, through June 30, 2028. The research project, titled "Macrophage-Centric Prognostic Biomarkers for Checkpoint Blockade Immunotherapy in Melanoma," focuses on developing and validating diagnostic biomarkers to improve patient...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $650,845 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The award, which began July 1, 2025, and extends through June 30, 2028, supports advanced biomedical research aimed at identifying and validating diagnostic tools to improve...
- The University of Alabama at Birmingham (UAB) was awarded a $1,485,001 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on March 1, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, titled "Overcoming Perturbations that Orchestrate Immune Exhaustion and Dysfunction in Breast Cancer,"...
- The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
- The Defense Health Agency awarded a $1,555,000 project grant to the University of Wisconsin System for the "Population Modeling to Optimize Equitable Ovarian Cancer Outcomes" research program under the Military Medical Research and Development (CFDA 12.420) federal grant program. The project, running from April 2025 to April 2029, will focus on advanced biomedical research to transform healthcare for military service members, veterans, and the public by developing novel diagnostic...
- This Project Grant award of $1,113,750.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports the University of Alabama at Birmingham (UAB) in developing "DUAL CD24/CD276 TARGETING THERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER." The 3-year award, running from August 1, 2023 to July 31, 2026, will fund research to investigate medical solutions for the battlefield and transform health care for service members and the public...